1. Its not finance facilities, they have raised money and given shares in exchange. So they can manufacture the device (right now) so they have stock to sell to customers, some money for marketing and supply chain.
2. Do not downplay CES, they have been to MEDICA and other industry specific events as well. Met many important and helpful people from around the globe.
3. The Pulse isn't their first product, they also have the SphygmoCor XCEL and Oscar 2, this is just a larger scale.
4. Financials will improve once Pulse units are being sold, not rocket science. They haven't released preorder numbers yet
5. Q2 FY25 will show direction?? Sales pick up fast?? How can sales pickup from a product which is not launched?? Pulse is a new product in the USA about to be launched, it's still in preorder. Sales will start, not "pick up".
6. having the Patent means that competitors cannot use our technology unless they buy out CDX or pay CDX money to use the technology in their devices.
which means no competition. If they use our technology Cardiex can sue them.
After the pulse there is the Conneqt BAND.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.94M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 49999 | 3.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.2¢ | 60000 | 1 |
View Market Depth
| Last trade - 16.21pm 26/06/2025 (20 minute delay) ? |
| CDX (ASX) Chart |
Day chart unavailable